Long-Term Cumulative High-Sensitivity C-Reactive Protein and Mortality Among Patients With Acute Heart Failure

Lihua Zhang1, Guangda He1, Xiqian Huo1

  • 1National Clinical Research Center for Cardiovascular Diseases, NHC Key Laboratory of Clinical Research for Cardiovascular Medications, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of China.

Insights

Elevated long-term cumulative high-sensitivity C-reactive protein (hsCRP) levels indicate a worse prognosis for patients hospitalized with heart failure. Repeated hsCRP measurements can help identify high-risk individuals for mortality.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation

Background:

  • Elevated high-sensitivity C-reactive protein (hsCRP) is linked to poorer outcomes in hospitalized heart failure patients.
  • The prognostic significance of long-term cumulative hsCRP levels in heart failure is not well understood.

Purpose of the Study:

  • To investigate the association between long-term cumulative hsCRP levels and mortality in patients hospitalized for heart failure.
  • To determine if repeated hsCRP measurements improve risk stratification for heart failure patients.

Main Methods:

  • Consecutive enrollment of 1281 heart failure patients, with hsCRP measurements at admission, 1 month, and 12 months post-discharge.
  • Evaluation of long-term cumulative hsCRP using quartiles and frequency of elevated levels (0-3 times) over the follow-up period.
  • Multivariable Cox regression models were employed to analyze the relationship between cumulative hsCRP and all-cause mortality over a median of 4.8 years.

Main Results:

  • Higher quartiles of cumulative hsCRP levels were significantly associated with increased mortality risk (HR for Q4 vs. Q1: 2.38).
  • Patients with more frequent elevated hsCRP levels (2 or 3 times) demonstrated substantially higher mortality risk compared to those with 0 times (HR for 3-times: 2.80).
  • A dose-response relationship was observed between increasing cumulative hsCRP burden and mortality.

Conclusions:

  • Increasing long-term cumulative hsCRP levels are a significant predictor of worse outcomes in patients hospitalized for acute heart failure.
  • Serial hsCRP measurements provide valuable prognostic information, aiding clinicians in identifying patients at high risk of death.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
185
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
14
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
18